Human serum, when treated with a 10-fold molar excess of HOCl (Human serum 10xHOCl), significantly decreases aggregation of chemically denatured citrate synthase as measured by light scattering at …
Numerical light scattering data obtained during protein aggregation assays represented in Figure 1a and b.
(a, b) Serum albumin in different concentrations, when treated with a 10- or 50-fold molar excess of HOCl (HSA 10xHOCl and HSA 50xHOCl, respectively), significantly decreases aggregation of …
Numerical light scattering data obtained during protein aggregation assays represented in Figure 2a and b.
Numerical light scattering data obtained during protein aggregation assays represented in Figure 2c and d.
Numerical light scattering data obtained during protein aggregation assays represented in Figure 2e and f.
Numerical light scattering data obtained during protein aggregation assays represented in Figure 2g and h.
Numerical light scattering data obtained during protein aggregation assays represented in Figure 2i and j.
(a) Representative measurements are shown. (b) Data represented as means and standard deviations from three independent experiments. Student’s t-test: ***p<0.001. Aggregation of citrate synthase in …
Numerical light scattering data obtained during protein aggregation assays represented in Figure 2—figure supplement 1.
(a) Representative measurements are shown. (b) Data represented as means and standard deviations from three independent experiments. Aggregation of citrate synthase in the absence of HSA was set to …
Numerical light scattering data obtained during protein aggregation assays represented in Figure 2—figure supplement 2.
(a) Untreated HSA and HSA treated with a 50-fold molar excess of HOCl and subsequently reduced with various reductants separated on a non-reducing gel. HOCl-treatment does not lead to accumulation …
Original scans of gels represented in Figure 2—figure supplement 3.
Taurine monochloramine was generated by incubation of 5 mM taurine with 50 µM HOCl. Taurine dichloramine was generated by incubation of 5 mM taurine with 10 mM HOCl. Untreated taurine or taurine …
Numerical light scattering data obtained during protein aggregation assays represented in Figure 2—figure supplement 4.
(a, b) Amino group content of variously treated HSA was analyzed using fluorescamine. Treatment of HSA with HOCl resulted in a dose-dependent loss of free amino groups. Reduction of chlorinated HSA …
Numerical fluorescence spectroscopy data obtained during determination of free amino groups represented in Figure 3a and b.
Numerical fluorescence spectroscopy data obtained during determination of protein chloramines represented in Figure 3c.
Numerical fluorescence spectroscopy data obtained during determination of protein chloramines represented in Figure 3d.
Numerical fluorescence spectroscopy data obtained during determination of protein hydrophobicity represented in Figure 3e.
Numerical fluorescence spectroscopy intensity data obtained during determination of protein hydrophobicity represented in Figure 3f.
(a) Measurement of the standard curve using known concentrations of taurine monochloramine. The standard curve is shown in Figure 3c in the main manuscript. (b) Determination of the content of …
Numerical fluorescence spectroscopy data obtained during determination of protein chloramines represented in Figure 3—figure supplement 1.
Treatment with a 50-fold molar excess of HOCl (HSA 50xHOCl) converted HSA into an efficient inducer of the neutrophil respiratory burst, reflected by the increased production and release of oxidants …
Numerical chemiluminescence plate reader data represented in Figure 4a and c.
Numerical chemiluminescence plate reader data represented in Figure 4b.
Treatment with a 50-fold molar excess of HOCl converted HSA into an efficient inducer of the neutrophil respiratory burst, irrespective of the preparation (1 mM HSA treated with 50 mM HOCl or 0.3 mM …
Numerical chemiluminescence plate reader data represented in Figure 4—figure supplement 1.
H2DCF-DA is a commonly used fluorescent probe for monitoring intracellular production of reactive oxygen species. H2DCF-DA was preincubated with 1xPBS for 15 min prior to the addition of native HSA …
Numerical chemiluminescence plate reader data represented in Figure 4—figure supplement 2.
(a) The model N-chloramine prepared in different ways (5 mM of taurine treated with either 50 µM or 10 mM of HOCl) at different molar excesses (1- or 99-fold the molarity of HSA used) did not lead …
Numerical chemiluminescence plate reader data represented in Figure 4—figure supplement 3.
α2-Macroglobulin (a, b), Cohn fraction IV (c, d) and the γ-globulin fraction (e, f) were analyzed for chaperone activity in a citrate synthase aggregation assay upon treatment with various doses of …
Numerical light scattering data obtained during protein aggregation assays represented in Figure 5a and b.
Numerical light scattering data obtained during protein aggregation assays represented in Figure 5c and d.
Numerical light scattering data obtained during protein aggregation assays represented in Figure 5e and f.
The effect of HOCl-treated α2-macroglobulin (α2M) (a, b), Cohn fraction IV (c, d) and the γ-globulin fraction (e, f) on the activity of the neutrophil NADPH oxidase was investigated. α2M, when …
Numerical chemiluminescence plate reader data represented in Figure 6a and b.
Numerical chemiluminescence plate reader data represented in Figure 6c and d.
Numerical chemiluminescence plate reader data represented in Figure 6e and f.
Effect of 10 μM diphenyleneiodonium (DPI; NADPH oxidase inhibitor), 100 nM wortmannin (PI3K inhibitor) and 200 nM Gö 6983 (protein kinase C (PKC) inhibitor) on the NADPH oxidase activation mediated …
Numerical chemiluminescence plate reader data represented in Figure 7a and d.
Numerical chemiluminescence plate reader data represented in Figure 7b and d.
Numerical chemiluminescence plate reader data represented in Figure 7c and d.
(a) The addition of catalase (CAT), superoxide dismutase (SOD) or both to differentiated PLB-985 cells incubated with HOCl-treated HSA prevented lucigenin chemiluminescence. (b) Results shown in a …
Numerical chemiluminescence plate reader data represented in Figure 7—figure supplement 1.
Differentiated neutrophil-like PLB-985 cells were preincubated with 50 μM Z-VAD-FMK, 155 μM native (HSA UT) or HOCl-treated HSA (HSA 50xHOCl) prior to the addition of 1 μM Ag85B or 2 μM …
Numerical flow cytometry data represented in Figure 8a and b.
(a, b) HSA, treated with a 50-fold molar excess of HOCl (HSA 50xHOCl) significantly decreased aggregation of denatured Ag85B as measured by light scattering at 360 nm. Reduction of HSA 50xHOCl with …
Numerical light scattering data obtained during protein aggregation assays represented in Figure 9a and b.
Numerical flow cytometry data obtained during protein aggregation assays represented in Figure 9c and d.
At the site of inflammation neutrophils (and potentially other immune cells) are activated. Neutrophils then produce HOCl at concentrations of up to 25 to 50 mM per hour. Plasma proteins, such as …
Relevant properties or genotype | Source or reference | |
---|---|---|
E. coli strains | ||
DH5α | supE44, ΔlacU169 (φ80 lacZΔM15) hsdR17 recA1 endA1 hsdR gyrA relA thi | Invitrogen |
BL21(DE3) | F– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI lacUV5- T7 gene one ind1 sam7 nin5]) | Stratagene, Santa Clara, CA |
Plasmids | ||
pEXA_fbpB | AmpR pEX-A128 vector carrying synthesized fbpB gene from M. bovis | Eurofins Genomics |
pET22b (+) | AmpR, vector for overexpression of genes in E. coli | Novagen |
pET22b-fbpB | AmpR, vector for overexpression of fbpB gene in E. coli BL21(DE3) | This study |
Primers | Sequence (5’ - > 3’) | |
fbpB-fw | CCCCATATGTTCTCTCGTCCGG | |
fbpB-rv | CCCCTCGAGACCAGCACCCAG |
* AmpR, ampicillin resistance.